15833-00-8 Usage
Description
2-(2-Aminophenyl)propan-2-ol, also known as N-isopropyl-2-aminophenol, is a chemical compound with the formula C9H13NO. It is a derivative of phenylpropanolamine and is commonly used as a reagent in organic synthesis. 2-(2-Aminophenyl)propan-2-ol serves as an intermediate in the synthesis of pharmaceuticals and agrochemicals, and is also utilized as a chiral auxiliary in asymmetric synthesis and as a building block for the preparation of various biologically active compounds. Its potential applications extend to the pharmaceutical industry, where it could be a starting material for the development of new drugs.
Uses
Used in Organic Synthesis:
2-(2-Aminophenyl)propan-2-ol is used as a reagent in organic synthesis for its ability to facilitate various chemical reactions, contributing to the formation of complex organic molecules.
Used in Pharmaceutical Synthesis:
In the pharmaceutical industry, 2-(2-Aminophenyl)propan-2-ol is used as an intermediate in the synthesis of various pharmaceuticals, playing a crucial role in the development of new drugs.
Used in Agrochemical Synthesis:
2-(2-Aminophenyl)propan-2-ol is also utilized in the synthesis of agrochemicals, where it serves as an intermediate to produce substances that help in the protection and management of crops.
Used as a Chiral Auxiliary:
2-(2-Aminophenyl)propan-2-ol is used as a chiral auxiliary in asymmetric synthesis, which is essential for the production of enantiomerically pure compounds, often required for biological activity and pharmaceutical applications.
Used in the Preparation of Biologically Active Compounds:
As a building block, 2-(2-Aminophenyl)propan-2-ol is used in the preparation of various biologically active compounds, contributing to the development of substances with potential therapeutic or other biological effects.
Used in Drug Development:
With its potential applications in the pharmaceutical industry, 2-(2-Aminophenyl)propan-2-ol could serve as a starting material for the development of new drugs, providing a foundation for innovative medicinal chemistry.
Check Digit Verification of cas no
The CAS Registry Mumber 15833-00-8 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 1,5,8,3 and 3 respectively; the second part has 2 digits, 0 and 0 respectively.
Calculate Digit Verification of CAS Registry Number 15833-00:
(7*1)+(6*5)+(5*8)+(4*3)+(3*3)+(2*0)+(1*0)=98
98 % 10 = 8
So 15833-00-8 is a valid CAS Registry Number.
InChI:InChI=1/C9H13NO/c1-9(2,11)7-5-3-4-6-8(7)10/h3-6,11H,10H2,1-2H3
15833-00-8Relevant articles and documents
Organocatalytic Atroposelective Construction of Axially Chiral N-Aryl Benzimidazoles Involving Carbon-Carbon Bond Cleavage
Man, Ningning,Lou, Zhenbang,Li, Yuming,Yang, Haijun,Zhao, Yufen,Fu, Hua
supporting information, p. 6382 - 6387 (2020/09/02)
Axially chiral compounds widely occur in natural products, biologically active molecules, ligands, and catalysts, and their efficient and enantioselective synthesis is highly desirable. Herein, we report a novel method for the atroposelective construction of axially chiral N-aryl benzimidazoles with chiral phosphoric acid as the organocatalyst via reaction of N1-(aryl)benzene-1,2-diamines with multicarbonyl compounds. The present method provided the target products in high yields (up to 89percent) with excellent enantioselectivity (up to 98percent ee).
Phosphorescent organic compound, preparation method thereof and organic electroluminescent device
-
Paragraph 0034-0038; 0050-0054; 0058-0062, (2020/12/30)
The invention discloses a phosphorescent organic compound, a preparation method of the phosphorescent organic compound and an organic electroluminescent device, and belongs to the field of chemical synthesis and photoelectric materials. The structural gen
CALICHEAMICIN DERIVATIVES AND ANTIBODY DRUG CONJUGATES THEREOF
-
Page/Page column 193, (2018/08/20)
The present invention is directed to novel calicheamicin derivatives useful as payloads in antibody-drug-conjugates (ADC's), and to payload-linker compounds and ADC compounds comprising the same; to pharmaceutical compositions comprising the same and to methods for using the same to treat pathological conditions such as cancer.